• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2020-2029  
Title Created Date
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177 Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N 30 August 2022
Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport 26 August 2022
Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma 25 August 2022
Melatonin Suppresses NLRP3 Inflammasome Activation via TLR4/NF-κB and P2X7R Signaling in High-Fat Diet-Induced Murine NASH Model 24 August 2022
Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression 23 August 2022
Anticancer properties of melatonin and its role as an adjuvant in cancer treatment 17 August 2022
Advances in nuclear medicine-based molecular imaging in head and neck squamous cell carcinoma 17 August 2022
Peptide Receptor Radionuclide Therapy in Thyroid Cancer 17 August 2022
Melatonin inhibits EMT and PD-L1 expression through the ERK1/2/FOSL1 pathway and regulates anti-tumor immunity in HNSCC 08 August 2022
Comprehensive Assessment of Somatostatin Receptors in Various Neoplasms: A Systematic Review 05 August 2022
Display # 

Page 43 of 90

  • Start
  • Prev
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • Next
  • End

Search

Follow us...

Latest

  • Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin
  • Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors
  • Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination
  • Melatonin attenuates bone cancer pain via the SIRT1/HMGB1 pathway
  • Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
  • Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients
  • A Review of Biological and Pharmacological Actions of Melatonin: Oxidant and Prooxidant Properties
  • Melatonin as Antioxidant Under Pathological Processes
  • Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage
  • Melatonin as antioxidant, geroprotector and anticarcinogen
  • The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor
  • Does the use of melatonin overcome drug resistance in cancer chemotherapy?
  • Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
  • Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
  • Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
  • Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms
  • Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management
  • Nocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer